# PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer

> **NCT00005916** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 48 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Neoplasm

## Interventions

- **DRUG:** rV-PSA
- **DRUG:** rF-PSA
- **DRUG:** rV-B7.1

## Key facts

- **NCT ID:** NCT00005916
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06-13
- **Primary completion:** —
- **Final completion:** 2005-12-22
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005916, "PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*